Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Gynecol Oncol. 2018 Apr;149(1):89-92. doi: 10.1016/j.ygyno.2017.10.023.
Patient navigation programs have been shown to positively impact cancer outcomes for minority populations. Little is known regarding the effects of these programs on American Indian (AI) populations. The purpose of this study is to characterize the impact of a patient navigation program on AI cervical cancer patients at a tertiary care center.
A retrospective review of all AI cervical cancer patients receiving navigation services and a cohort of AI patients treated prior to navigation services was performed. Additional comparisons were made between those with and without Indian Health Service (IHS) funding. Summary statistics were used to describe demographic, clinical characteristics, treatment, and survivorship across groups.
Of 55 patients identified, 34 received navigation and 21 did not. In navigated patients, median age was 46years (27-80years) compared with 42years (17-68years) in pre-navigation patients (p=0.53). There was no difference between stage at diagnosis (p=0.73). No difference was noted in treatment received between groups (p=0.48). Distance traveled for treatment between groups did not differ (p=0.46). Median time to initiation of treatment was not different between groups, 30.5days vs. 27.5days (p=0.18). Among patients with IHS funding, navigation services did not alter time to initiation of treatment (p=0.57), and there was no difference in completion of prescribed therapy between groups (92% navigated vs 100% pre-navigation).
Navigation services for AI cervical cancer patients did not alter initiation or completion of treatment. Navigation programs may provide less tangible benefits to AI cervical cancer patients and further study is warranted.
患者导航计划已被证明对少数族裔的癌症结果产生积极影响。对于这些计划对美洲印第安人(AI)人群的影响知之甚少。本研究的目的是描述在三级保健中心为 AI 宫颈癌患者提供患者导航计划的效果。
对所有接受导航服务的 AI 宫颈癌患者以及在接受导航服务之前接受治疗的 AI 患者队列进行回顾性审查。还比较了那些有和没有印度卫生服务(IHS)资助的患者。使用汇总统计数据描述各组之间的人口统计学、临床特征、治疗和生存情况。
在确定的 55 名患者中,34 名接受了导航治疗,21 名未接受导航治疗。在接受导航治疗的患者中,中位年龄为 46 岁(27-80 岁),而在接受导航治疗前的患者中为 42 岁(17-68 岁)(p=0.53)。诊断时的分期无差异(p=0.73)。两组之间接受的治疗无差异(p=0.48)。两组之间治疗的旅行距离没有差异(p=0.46)。两组之间开始治疗的中位时间没有差异,分别为 30.5 天和 27.5 天(p=0.18)。在有 IHS 资助的患者中,导航服务并未改变开始治疗的时间(p=0.57),并且两组之间完成规定治疗的情况也没有差异(92%接受导航治疗的患者与 100%接受导航治疗前的患者)。
AI 宫颈癌患者的导航服务并未改变治疗的开始或完成情况。导航计划可能对 AI 宫颈癌患者提供较少的无形收益,需要进一步研究。